3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Myelodysplastic Syndromes
5
Burkitt Lymphoma
4
Multiple Myeloma
2
Lymphoma, Large-Cell, Anaplastic
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Biphenotypic, Acute
2
Ganglioneuroblastoma
2
Smoldering Multiple Myeloma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroblastoma
1
Myeloproliferative Disorders
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Prolymphocytic
1
Leukemia, Plasma Cell
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Immunoglobulin Light-chain Amyloidosis
1
Hodgkin Disease
1
Graft vs Host Disease
1
Interventions
Bevacizumab
13
atezolizumab
9
Specimen Handling
9
durvalumab
8
Nivolumab
7
Magnetic Resonance Spectroscopy
7
tremelimumab
6
lenvatinib
6
cabozantinib
4
Sorafenib
4
tislelizumab
3
donafenib
3
X-Rays
3
Surgical Procedures, Operative
3
Oxaliplatin
3
Ipilimumab
3
Immunotherapy
3
Fluorouracil
3
ulixertinib
2
sintilimab
2
sapanisertib
2
relatlimab
2
pembrolizumab
2
camrelizumab
2
apatinib
2
Leucovorin
2
Irinotecan
2
Fluorodeoxyglucose F18
2
Doxorubicin
2
Carboplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Stem Cell Transplantation
×
30 days
×
Clear all
No trials found.